arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Outset Medical, Inc.

$4.89 ▼ -0.29 (-5.69%) at close

9 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Outset Medical, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 5.1% ↗

Op. Margin -55.8% ↗

ROIC -30.2% ↗

FCF / Share —

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity 0.76

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$119.48M

↑ +5.1% —

Net Income Profit after all expenses

$-81.65M

↑ +36.2% —

Operating Margin Operating profit as % of sales

-55.8%

↑ +44.0% 5th

Long-Term Debt Long-term obligations

$96.24M

↓ -51.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	5.1% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-36%)	-12.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-260%)	13.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+63%)	12.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+56%)	105.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1218%)	231.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2790%)	651.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8041%)	—	—
EPS Growth YoY (%)	-118.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	29.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-17.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	36.2% Excellent ↑ Excellent Improving Year-over-year change in net income	25.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-6.0% Weak ↑ Weak Improving Year-over-year change in net income	-23.5% Weak ↑ Weak Improving Year-over-year change in net income	-8.6% Weak ↑ Weak Improving Year-over-year change in net income	-77.9% Weak Weak Year-over-year change in net income	-37.2% Weak Weak Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	1.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	3.5% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	37.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	97.1% Excellent Excellent Compound annual revenue growth over 3 years	271.1% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	19.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	49.8% Excellent Excellent Compound annual revenue growth over 5 years	130.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	-55.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-472%)	-99.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-765%)	-130.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-968%)	-139.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1030%)	-127.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-948%)	-235.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1668%)	-466.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3209%)	—	—
Effective Tax Rate (%) (%)	-0.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-68.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-670%)	-112.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1038%)	-132.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1204%)	-141.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1277%)	-128.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1172%)	-243.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2128%)	-453.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3875%)	—	—
FCF Margin (%) (%)	-39.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-103.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-103.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-133.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-130.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-216.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-488.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-30.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-67.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	20.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	16.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-25.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-54.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-79.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-64.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-529%)	—	-140.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1037%)	-66.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-542%)	-35.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	-37.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-346%)	18.4% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+22%)	17.3% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	0.76x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+26%)	7.36x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1127%)	1.06x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+76%)	0.39x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	0.08x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	0.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-85%)	-0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-113%)	—	—
Interest Coverage (x)	-4.78x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.75x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.39x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-45.15x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-76.10x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-40.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	-10.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$61.23M	$73.36M	$61.60M	$23.11M	$-152.59M	$-265.30M	$-7.87M	—	—
Debt / EBITDA (x)	-1.54x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.83x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.79x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.62x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.24x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.26x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.42x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Basic EPS, GAAP (USD)	$-5.37	$-2.46	$-3.48	$-3.38	$-2.89	—	—	—	—
Book Value per Share (USD)	$6.99	$0.51	$2.44	$5.08	$7.92	$7.69	$-403.67	—	—
Tangible Book Value per Share (USD)	$6.99	$0.51	$2.44	$5.08	$7.92	$7.69	$-403.67	—	—
Basic Weighted Avg Shares (shares)	15,211	51,951	49,588	48,161	45,589	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$213.25M	$212.84M	$235.90M	$321.70M	$358.11M	$309.22M	$54.74M	—	—
LT Debt (USD)	$96.24M	$197.38M	$130.11M	$96.34M	$29.76M	$29.67M	$29.06M	—	—
Total Equity (USD)	$126.95M	$26.82M	$122.89M	$245.99M	$374.08M	$328.61M	$-372.19M	$-287.95M	$-215.94M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$119.48M	$113.69M	$130.38M	$115.38M	$102.60M	$49.94M	$15.08M	$2.01M	—
Depreciation Expense (USD)	$4.34M	$5.73M	$5.81M	$5.17M	$5.16M	$3.16M	$1.48M	$1.07M	—
Net Income, GAAP (USD)	$-81.65M	$-127.98M	$-172.80M	$-162.96M	$-131.94M	$-121.49M	$-68.30M	$-49.78M	—
Operating Cash Flow (USD)	$-46.33M	$-116.30M	$-131.37M	$-145.73M	$-130.26M	$-99.02M	$-70.29M	$-46.44M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 31 quarters

Outset Medical, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OM with peers